Immediate Impact
1 from Science/Nature 55 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of Chun-Nin Lee being referenced
Bevacizumab Reduces S100A9-Positive MDSCs Linked to Intracranial Control in Patients with EGFR-Mutant Lung Adenocarcinoma
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Chun-Nin Lee | 131 | 113 | 54 | 104 | 28 | 500 | |
| Jun Fei | 170 | 101 | 45 | 82 | 26 | 522 | |
| Xiaodong Zhao | 91 | 38 | 47 | 100 | 50 | 548 | |
| Megan Meyer | 116 | 29 | 80 | 92 | 19 | 516 | |
| Anna Bulgheroni | 89 | 49 | 44 | 140 | 20 | 518 | |
| Jun Qian | 51 | 56 | 91 | 68 | 36 | 448 | |
| Jeong Woong Park | 177 | 45 | 40 | 109 | 43 | 486 | |
| Peng Ding | 58 | 66 | 54 | 44 | 38 | 496 | |
| C. Thomas Boylen | 176 | 116 | 40 | 74 | 20 | 507 | |
| Naushad Ahmad Khan | 116 | 47 | 18 | 71 | 33 | 470 | |
| Huang-Yang Chen | 102 | 93 | 124 | 27 | 19 | 539 |
All Works
Loading papers...